Castle Biosciences (CSTL) Cash from Operations Growth (3y) (2021 - 2026)
Castle Biosciences (CSTL) Cash from Operations Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 11.33% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -9.46% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 20.12% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -11.38% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.55% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 35.64% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 24.17% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 5.18% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.37% |
| 10 | Castle Biosciences | 926.56 Mn | 659.75 Mn | 79.85 Mn | 81.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 81.86% |
| Mar 31, 2026 | 4.54% |
| Dec 31, 2025 | 86.52% |
| Sep 30, 2025 | 85.00% |
| Jun 30, 2025 | 62.78% |
| Mar 31, 2025 | 34.45% |
| Dec 31, 2024 | 120.78% |
| Sep 30, 2024 | 79.73% |
| Jun 30, 2024 | 78.92% |
| Mar 31, 2024 | -23.47% |
| Dec 31, 2023 | 256.28% |
| Sep 30, 2023 | 54.61% |
| Jun 30, 2023 | -31.63% |
| Mar 31, 2023 | -366.24% |
| Dec 31, 2022 | -49.41% |
| Sep 30, 2022 | -107.60% |
| Jun 30, 2022 | -174.46% |
| Mar 31, 2022 | -165.14% |
| Dec 31, 2021 | 4.68% |
| Sep 30, 2021 | -48.35% |